Di-tert-butyl 8-chloro-2,3-dihydro-1H-benzo[e][1,4]diazepine-1,4(5H)-dicarboxylate

Catalog No. :
ACJWBS750
CAS No. :
1416438-28-2
Molecular Formula :
C19H27ClN2O4
Molecular Weight :
382.89

IUPAC Name:di-tert-butyl 8-chloro-2,3-dihydro-1H-benzo[e][1,4]diazepine-1,4(5H)-dicarboxylate

Di-tert-butyl 8-chloro-2,3-dihydro-1H-benzo[e][1,4]diazepine-1,4(5H)-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$665.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDi-tert-butyl 8-chloro-2,3-dihydro-1H-benzo[e][1,4]diazepine-1,4(5H)-dicarboxylate
IUPAC Namedi-tert-butyl 8-chloro-2,3-dihydro-1H-benzo[e][1,4]diazepine-1,4(5H)-dicarboxylate
MDL No.MFCD22690288
Molecular FormulaC19H27ClN2O4
Molecular Weight382.89
SMILESO=C(N1CCN(C(OC(C)(C)C)=O)CC2=CC=C(Cl)C=C12)OC(C)(C)C
InChI KeyWWBVQUSWFATRSC-UHFFFAOYSA-N
SynonymDI-TERT-BUTYL 8-CHLORO-2,3-DIHYDRO-1H-BENZO[E][1,4]DIAZEPINE-1,4(5H)-DICARBOXYLATE;1H-1,4-Benzodiazepine-1,4(5H)-dicarboxylic acid, 8-chloro-2,3-dihydro-, 1,4-bis(1,1-dimethylethyl) ester
CAS No.1416438-28-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJWBS750 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJWBS750 route product structure diagram
    ACJWBS7501416438-28-2
Inquiry

2. ACJWBS750 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJWBS750 route product structure diagram
    ACJWBS7501416438-28-2
Inquiry

Comments (0)